The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
The global Cell Therapy market was valued at US$ 101000 million in 2023 and is anticipated to reach US$ 250460 million by 2030, witnessing a CAGR of 13.5% during the forecast period 2024-2030.
The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.
Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.
North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.
This report aims to provide a comprehensive presentation of the global market for Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy.
Report Scope
The Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Gilead Sciences
- Novartis
- Osiris
- Vericel Corporation
- Vcanbio
- Fujifilm Cellular Dynamics
- JCR Pharmaceuticals
- Beike Biotechnology
- Golden Meditech
- Guanhao Biotech
Segment by Type
- Stem Cell
- Non-Stem Cell
Segment by Application
- Hospital
- Clinic
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy Market Perspective (2019-2030)
2.2 Cell Therapy Growth Trends by Region
2.2.1 Global Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Cell Therapy Market Dynamics
2.3.1 Cell Therapy Industry Trends
2.3.2 Cell Therapy Market Drivers
2.3.3 Cell Therapy Market Challenges
2.3.4 Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy Players by Revenue
3.1.1 Global Top Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy Revenue
3.4 Global Cell Therapy Market Concentration Ratio
3.4.1 Global Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Revenue in 2023
3.5 Cell Therapy Key Players Head office and Area Served
3.6 Key Players Cell Therapy Product Solution and Service
3.7 Date of Enter into Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy Breakdown Data by Type
4.1 Global Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Cell Therapy Breakdown Data by Application
5.1 Global Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell Therapy Market Size (2019-2030)
6.2 North America Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell Therapy Market Size by Country (2019-2024)
6.4 North America Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy Market Size (2019-2030)
7.2 Europe Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Therapy Market Size (2019-2030)
9.2 Latin America Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Cell Therapy Introduction
11.1.4 Gilead Sciences Revenue in Cell Therapy Business (2019-2024)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Cell Therapy Introduction
11.2.4 Novartis Revenue in Cell Therapy Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Osiris
11.3.1 Osiris Company Detail
11.3.2 Osiris Business Overview
11.3.3 Osiris Cell Therapy Introduction
11.3.4 Osiris Revenue in Cell Therapy Business (2019-2024)
11.3.5 Osiris Recent Development
11.4 Vericel Corporation
11.4.1 Vericel Corporation Company Detail
11.4.2 Vericel Corporation Business Overview
11.4.3 Vericel Corporation Cell Therapy Introduction
11.4.4 Vericel Corporation Revenue in Cell Therapy Business (2019-2024)
11.4.5 Vericel Corporation Recent Development
11.5 Vcanbio
11.5.1 Vcanbio Company Detail
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cell Therapy Introduction
11.5.4 Vcanbio Revenue in Cell Therapy Business (2019-2024)
11.5.5 Vcanbio Recent Development
11.6 Fujifilm Cellular Dynamics
11.6.1 Fujifilm Cellular Dynamics Company Detail
11.6.2 Fujifilm Cellular Dynamics Business Overview
11.6.3 Fujifilm Cellular Dynamics Cell Therapy Introduction
11.6.4 Fujifilm Cellular Dynamics Revenue in Cell Therapy Business (2019-2024)
11.6.5 Fujifilm Cellular Dynamics Recent Development
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Detail
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Cell Therapy Introduction
11.7.4 JCR Pharmaceuticals Revenue in Cell Therapy Business (2019-2024)
11.7.5 JCR Pharmaceuticals Recent Development
11.8 Beike Biotechnology
11.8.1 Beike Biotechnology Company Detail
11.8.2 Beike Biotechnology Business Overview
11.8.3 Beike Biotechnology Cell Therapy Introduction
11.8.4 Beike Biotechnology Revenue in Cell Therapy Business (2019-2024)
11.8.5 Beike Biotechnology Recent Development
11.9 Golden Meditech
11.9.1 Golden Meditech Company Detail
11.9.2 Golden Meditech Business Overview
11.9.3 Golden Meditech Cell Therapy Introduction
11.9.4 Golden Meditech Revenue in Cell Therapy Business (2019-2024)
11.9.5 Golden Meditech Recent Development
11.10 Guanhao Biotech
11.10.1 Guanhao Biotech Company Detail
11.10.2 Guanhao Biotech Business Overview
11.10.3 Guanhao Biotech Cell Therapy Introduction
11.10.4 Guanhao Biotech Revenue in Cell Therapy Business (2019-2024)
11.10.5 Guanhao Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
